Ipratropium Nasal Spray: Generic Alternative to Atrovent

  Published 11 months ago

Ipratropium Bromide Nasal Solution is a bioequivalent to Atrovent for treating rhinorrhea in adults and children aged 6+; U.S. sales reached $63M in May 2025.

  • Lupin, a global pharmaceutical leader, offers this solution in over 100 markets with diverse product portfolios.
  • Indicated for allergic and nonallergic perennial rhinitis, providing symptomatic relief for nasal discharge.
  • IQVIA data shows $63 million in annual U.S. sales in May 2025 for the RLD Atrovent equivalent formulation.

You might like these

L&T Plans Green Hydrogen Plant

Union Bank Slips on Margin Woes

Swiggy Shares Slide on Wider Losses

India Eases Research Rules to Spur Innovation

Mobikwik Fraud Hits Shares, 260M Rupee Loss

Aditya Birla AMC Reports Steady Growth

Omaxe Expands in Madhya Pradesh with Rs. 1,200 Crore Township

News that matters the most ⚡